Summary:
Six to seven million people in the world live with Chagas disease, a subset of whom will develop Chagas heart disease potentially requiring heart transplantation. In this webinar we will discuss the etiology, pathology, and management of Chagas heart disease, both pre- and post-heart transplantation.
Moderator(s): Gregory A. Fishbein, MD and Me-Linh Luong, MD
Welcome and Introductions
Moderator: Gregory A. Fishbein, MD, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Introduction to Chagas Disease
Silvia V. Campos, PhD, Hospital das Clínicas da Faculdade de Medicina da Univ. de São Paulo, Brazil
This talk will describe the epidemiology and parasitology of Chagas disease, as well as the current state and availability of laboratory testing.
Pre-Transplant Management of the Chagas Patient
Margarita Peradejori, MD, Hospital de Alta Complejidad El Cruce, Buenos Aires, Argentina
This talk will describe the clinical manifestations of Chagas heart disease, the role of diagnostic testing, and strategies for managing the infection, acute phase disease, and chronic Chagas cardiomyopathy.
Pathology of the Explanted Chagas Heart
Daniel Luthringer, MD, Cedars-Sinai Medical Center, Los Angeles, USA
A subset of patients with Chagas heart disease will undergo heart transplantation. This talk will describe the pathogenesis of Chagas heart disease and spectrum of pathologic findings encountered in the explanted Chagas heart.
Post-Transplant Management of the Chagas Patient
Sandra Chaparro, MD, Baptist Health South Florida, Florida International University, Miami, FL, USA
Management of the Chagas patient after heart transplantation requires unique considerations. This talk will describe strategies for immunosuppression, surveillance, and the treatment/prevention of T cruzi reactivation in the post-transplant Chagas patient.
Q&A Segment with All Speakers
Led by Moderator(s)
Closing Remarks
Moderator: Me-Linh Luong, MD, University of Montréal, Montréal, Quebec, Canada
ISHLT Announcements
Greg Schultz, ISHLT CEO
